{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:41:16Z","timestamp":1791942076655,"version":"4.3.4"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Korean Association of Endocrine Surgeons"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Data on epidemiology and secular trend in primary hyperparathyroidism (PHPT) in adults are relatively limited in Asian countries. This study aims to provide an overview of the secular trends in incidence, clinical characteristics, and treatment patterns of PHPT in South Korea. We used Korea\u2019s National Health Insurance Claim database (2005-2020) to identify newly diagnosed PHPT cases. Individuals with age below 19, fewer than 2 E21.0 diagnoses, fewer than 2 PTH measurements, secondary hyperparathyroidism, undergoing dialysis or kidney transplantation within a year of diagnosis, parathyroidectomy (PTX) within a year prior to the diagnosis code, and diagnosis of multiple endocrine neoplasm or parathyroid carcinoma were excluded from the analysis. A total of 6837 patients with PHPT (PTX, n\u2009=\u20092989; non-surgery, n\u2009=\u20093848) were compared with 1:10 age- and sex-matched controls (n\u2009=\u200968\u2009370). The mean age of patients with PHPT was 56.0\u00a0years, with 77.4% being women. The annual incidence of PHPT increased from 0.23\/100 000 persons in 2005 to 1.75 in 2020, with higher rate in women than in men. Compared with 2005-2010 (n\u2009=\u2009675), the number of newly diagnosed PHPT cases increased up to 3.1-fold (n\u2009=\u20092119) in 2011-2015 and 6.0-fold (n\u2009=\u20094043) in 2016-2020 periods. Among all patients with PHPT, 43.7% of patients underwent PTX, with decrement of proportion of bilateral surgery among PTX group across time (11.9% in 2005-2010 to 8.9% in 2016-2020, P for trend .033). Among all patients with PHPT, non-surgery group increased from 41.6% in 2005-2010 to 58.0% in 2016-2020 (P for trend &amp;lt;.001). Patients with PHPT had higher odds of osteoporosis (odds ratio [OR] 7.03), renal stones (OR 10.55), chronic kidney diseases (OR 7.42), and cardiovascular, metabolic, and neurological conditions after adjustment for comorbidity index. In summary, the incidence of PHPT increased from 2005 to 2020 with predominance of non-surgical treatment, which calls for research focus on improving non-surgical management.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziae065","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T12:36:39Z","timestamp":1715344599000},"source":"Crossref","is-referenced-by-count":12,"title":["Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study"],"prefix":"10.1093","volume":"8","author":[{"given":"Kyoung Jin","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism , Department of Internal Medicine, , Seoul 02841 , Republic of Korea"},{"name":"Korea University College of Medicine , Department of Internal Medicine, , Seoul 02841 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungjin","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"},{"name":"Yonsei University College of Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Heui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"},{"name":"Yonsei University College of Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjae","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Health Insurance Service Ilsan Hospital , Goyang 10444 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjoon","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"},{"name":"Yonsei University College of Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"},{"name":"Yonsei University College of Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"},{"name":"Yonsei University College of Medicine , Endocrine Research Institute, , Seoul 03722 , Republic of Korea"},{"name":"Institute for Innovation in Digital Healthcare, Yonsei University , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"issue":"3","key":"2024061205462212000_ref1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024061205462212000_ref2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK","volume":"71","author":"Yu","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024061205462212000_ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"issue":"1","key":"2024061205462212000_ref4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12020-022-03211-8","article-title":"Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism","volume":"79","author":"Kong","year":"2023","journal-title":"Endocrine"},{"issue":"3","key":"2024061205462212000_ref5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3803\/EnM.2021.1061","article-title":"Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach","volume":"36","author":"Zavatta","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"2024061205462212000_ref6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2024061205462212000_ref7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2024061205462212000_ref8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ecl.2021.07.006","article-title":"Sporadic primary hyperparathyroidism","volume":"50","author":"Kim","year":"2021","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"11","key":"2024061205462212000_ref9","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024061205462212000_ref10","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"11","key":"2024061205462212000_ref11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024061205462212000_ref12","first-page":"A4567","article-title":"Increasing incidence of primary hyperparathyroidism in Denmark","volume":"60","author":"Abood","year":"2013","journal-title":"Dan Med J"},{"issue":"2","key":"2024061205462212000_ref13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14712\/23362936.2015.50","article-title":"Changes in the pattern of primary hyperparathyroidism in Czech Republic","volume":"116","author":"Broul\u00edk","year":"2015","journal-title":"Prague Med Rep"},{"issue":"5","key":"2024061205462212000_ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4174\/astr.2018.94.5.235","article-title":"The prevalence of primary hyperparathyroidism in Korea: a population-based analysis from patient medical records","volume":"94","author":"Kim","year":"2018","journal-title":"Ann Surg Treat Res"},{"issue":"6","key":"2024061205462212000_ref15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"issue":"10","key":"2024061205462212000_ref16","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1210\/clinem\/dgad201","article-title":"Stable incidence and increasing prevalence of primary hyperparathyroidism in a population-based study in Scotland","volume":"108","author":"Soto-Pedre","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024061205462212000_ref17","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10391","article-title":"Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed?","volume":"4","author":"Zavatta","year":"2020","journal-title":"JBMR Plus"},{"issue":"4","key":"2024061205462212000_ref18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11154-020-09614-0","article-title":"Skeletal abnormalities in hypoparathyroidism and in primary hyperparathyroidism","volume":"22","author":"Silva","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2024061205462212000_ref19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12020-019-02099-1","article-title":"Risk factors for vertebral fracture in primary hyperparathyroidism","volume":"66","author":"Liu","year":"2019","journal-title":"Endocrine"},{"key":"2024061205462212000_ref20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jss.2018.07.028","article-title":"Timely evaluation and management of primary hyperparathyroidism in patients with kidney stones","volume":"232","author":"Perez","year":"2018","journal-title":"J Surg Res"},{"issue":"1","key":"2024061205462212000_ref21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.surg.2018.04.088","article-title":"End-organ effects of primary hyperparathyroidism: a population-based study","volume":"165","author":"Assadipour","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"2024061205462212000_ref22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.surg.2019.05.094","article-title":"Coronary artery disease is more severe in patients with primary hyperparathyroidism","volume":"167","author":"Koubaity","year":"2020","journal-title":"Surgery"},{"issue":"3","key":"2024061205462212000_ref23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/lary.26617","article-title":"Early neurocognitive improvements following parathyroidectomy for primary hyperparathyroidism","volume":"128","author":"Shah-Becker","year":"2018","journal-title":"Laryngoscope"},{"issue":"3","key":"2024061205462212000_ref24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40618-019-01128-0","article-title":"Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy","volume":"43","author":"Liu","year":"2020","journal-title":"J Endocrinol Investig"},{"key":"2024061205462212000_ref25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.maturitas.2020.04.006","article-title":"Non-surgical management of primary hyperparathyroidism in the aging population","volume":"136","author":"Cipriani","year":"2020","journal-title":"Maturitas"},{"key":"2024061205462212000_ref26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2020.02.010","article-title":"Hyperparathyroidism in patients over 75: clinical characteristics and outcome. Is conservative treatment a safe alternative?","volume":"135","author":"Duskin-Bitan","year":"2020","journal-title":"Maturitas"},{"issue":"11","key":"2024061205462212000_ref27","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024061205462212000_ref28","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziae065\/57572099\/ziae065.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/7\/ziae065\/58199181\/ziae065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/7\/ziae065\/58199181\/ziae065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:46:48Z","timestamp":1718171208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziae065\/7671051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziae065","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,13]]},"article-number":"ziae065"}}